AU2004906888A0 - Identification of compounds for the treatment of proliferative disorders - Google Patents

Identification of compounds for the treatment of proliferative disorders

Info

Publication number
AU2004906888A0
AU2004906888A0 AU2004906888A AU2004906888A AU2004906888A0 AU 2004906888 A0 AU2004906888 A0 AU 2004906888A0 AU 2004906888 A AU2004906888 A AU 2004906888A AU 2004906888 A AU2004906888 A AU 2004906888A AU 2004906888 A0 AU2004906888 A0 AU 2004906888A0
Authority
AU
Australia
Prior art keywords
identification
compounds
treatment
proliferative disorders
proliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004906888A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Alexandra Hospital for Children
Original Assignee
Royal Alexandra Hospital for Children
Filing date
Publication date
Application filed by Royal Alexandra Hospital for Children filed Critical Royal Alexandra Hospital for Children
Publication of AU2004906888A0 publication Critical patent/AU2004906888A0/en
Priority to PCT/AU2005/001810 priority Critical patent/WO2006058375A1/en
Abandoned legal-status Critical Current

Links

AU2004906888A 2004-12-01 2004-12-01 Identification of compounds for the treatment of proliferative disorders Abandoned AU2004906888A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2005/001810 WO2006058375A1 (en) 2004-12-01 2005-12-01 Identification of compounds for the treatment of proliferative disorders

Publications (1)

Publication Number Publication Date
AU2004906888A0 true AU2004906888A0 (en) 2004-12-16

Family

ID=

Similar Documents

Publication Publication Date Title
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
IL185016A0 (en) Compounds for the treatment of proliferative disorders
EP1853539A4 (en) Honokiol derivatives for the treatment of proliferative disorders
IL187168A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
TWI372146B (en) Imidazole compounds for the treatment of neurodegenerative disorders
IL178648A0 (en) Substituted morpholine compounds for the treatment of central nervous system disorders
PL2001892T3 (en) Imidazolothiazole compounds for the treatment of proliferative diseases
AU2007288337A8 (en) Compounds for treating proliferative disorders
ZA200803440B (en) Compounds for the treatment of metabolic disorders
HK1163672A1 (en) Processes for the preparation of compounds
EP1654260A4 (en) 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders
EP1658072A4 (en) Compounds for the treatment of neurodegenerative disorders
IL177955A0 (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
IL188390A0 (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
EP1740530B8 (en) Substituted phenoxy- and phenylthio-derivatives for treating proliferative disorders
HK1097831A1 (en) Benzopyran compounds useful for the treatment of arrhytmia
EP1890711A4 (en) Compounds for treating or preventing amine oxidase related diseases or disorders
EP1653952A4 (en) Oxazole compounds for the treatment of neurodegenerative disorders
GB0400802D0 (en) Compounds for the treatment of disease
EP1755637B8 (en) Methods for preventing or treating bone disorders
AU2004906888A0 (en) Identification of compounds for the treatment of proliferative disorders
ZA200606780B (en) Compounds for the treatment of diseases
IL178960A0 (en) Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
IL175611A0 (en) Combinations for the treatment of proliferative diseases
ZA200800409B (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders